Drug Type Small molecule drug |
Synonyms EpiCeptMP/DP, EpiCeptMS Spray, LidoPAINMP/DP + [2] |
Action agonists, modulators |
Mechanism Opioid receptors agonists(Opioid receptors agonists), SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H22N2O |
InChIKeyNNJVILVZKWQKPM-UHFFFAOYSA-N |
CAS Registry137-58-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Phase 2 | United States | - | |
Pain | Phase 2 | - | - |
Early Phase 1 | 229 | (Receiving 0.1 mg IT Morphine) | vzetwdbvxp(wjoikbothn) = anmjeoifre nkkernlire (ziyrjszpqt, txmjgykrwj - xgdfncwzql) View more | - | 19 Dec 2024 | ||
(Recieving 0.05 mg IT Morphine) | vzetwdbvxp(wjoikbothn) = ukohtdchuj nkkernlire (ziyrjszpqt, pdewvgmpdc - ykvyrmsbcr) View more |